Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03150693 |
Recruitment Status :
Recruiting
First Posted : May 12, 2017
Last Update Posted : April 19, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
B Acute Lymphoblastic Leukemia | Drug: Allopurinol Drug: Cytarabine Drug: Daunorubicin Hydrochloride Drug: Vincristine Sulfate Drug: Dexamethasone Drug: Pegylated L-Asparaginase Drug: Methotrexate Procedure: Bone Marrow Aspiration and Biopsy Drug: Cyclophosphamide Drug: Mercaptopurine Biological: Rituximab Drug: Doxorubicin Drug: Thioguanine Biological: Inotuzumab Ozogamicin Other: Laboratory Biomarker Analysis | Phase 3 |


PRIMARY OBJECTIVES:
I. To confirm tolerability of the combination regimen with the addition of inotuzumab ozogamicin to the pediatric-inspired regimen of cancer and leukemia group B (CALGB) 10403.
II. To determine whether the addition of inotuzumab ozogamicin significantly improves the event-free survival (EFS) in patients who achieve an induction response achieved with the pediatric-inspired regimen of CALGB 10403, without censoring for transplant. (Phase III)
SECONDARY OBJECTIVES:
I. To determine the impact of inotuzumab ozogamicin on disease-free (DFS) and overall survival (OS) in patients who achieve an induction response.
II. To determine whether the addition of inotuzumab ozogamicin significantly improves the event-free survival (EFS) in patients who achieve an induction response achieved with the pediatric-inspired regimen of CALGB 10403, with censoring for transplant.
III. To determine the impact of inotuzumab ozogamicin on minimal residual disease (MRD) and correlate this with the EFS, DFS and OS.
IV. To determine the prognosis based on patients' low-density array (LDA) gene signature in terms of EFS, DFS, and OS after treatment with or without inotuzumab ozogamicin when added to the C10403 backbone regimen.
V. To evaluate the toxicity and tolerability of the addition of inotuzumab ozogamicin to the pediatric-inspired regimen of CALGB 10403.
TERTIARY OBJECTIVES:
I. To assess both the correlation of MRD post-induction and at sequential timepoints with LDA signature.
II. To evaluate the influence of MRD status (detectable vs. not and as a continuous measure) in relation to EFS both in the univariate setting as well as adjusting for other clinical features including initial white blood cell (WBC), ethnicity, gender and age at diagnosis.
III. To evaluate the impact of inotuzumab ozogamicin (inotuzumab) on the kinetics of MRD during treatment with inotuzumab in patients randomized to the experimental treatment arm.
IV. To perform genomic analyses to identify and evaluate the incidence and clinical significance of recurring novel fusion genes including those associated with the BCR-ABL1-like signature and to correlate with MRD status, CR rate, EFS and OS.
V. To assess whether rs4958351 is correlated with L-asp allergic reaction in the adolescent and young adult (AYA) population.
VI. To assess the incidence of inherited genetic variants in the GR1A1, CEP72, CPA2, TPMT, NUDT15, GRIN3A, GRIK1, and other genes (which can be found using a whole genome association study [GWAS]), are correlated with increased rates of target toxicities including peripheral neuropathy, hepatotoxicity, pancreatitis, myelosuppression, neurotoxicity, thrombosis, and osteonecrosis, and correlate with treatment discontinuation and other clinical response parameters including complete response (CR) rate, EFS, and OS.
VII. To evaluate asparaginase pharmacokinetics in adolescents and young adults, and investigate its correlation with toxicities and treatment outcomes.
VIII. To investigate the effect of anti-polyethylene glycol (PEG) and anti-agouti signaling protein (ASP) antibodies (PEG-ASP) on ASP enzyme activity.
IX. To measure adherence to oral 6 mercaptopurine (MP) and methotrexate in AYAs with acute lymphoblastic leukemia (ALL) and to examine sociodemographic and behavioral determinants of adherence.
X. To determine the impact of adherence on risk of relapse among AYAs with ALL.
OUTLINE:
COURSE I (REMISSION INDUCTION THERAPY): All patients receive allopurinol orally (PO) once daily until peripheral blasts and extramedullary disease are reduced and cytarabine intrathecally (IT) over 1 minute on day 1. Patients also receive daunorubicin hydrochloride intravenously (IV) and vincristine sulfate IV on days 1, 8, 15 and 22, dexamethasone PO or IV twice daily (BID) on days 1-7 and 15-21, pegylated L-aspiraginase IV on day 4, 5, or 6, and methotrexate IT over 1 minute on days 8 and 29. Patients with central nervous system (CNS) 3 disease receive methotrexate IT over 1 minute also on days 15 and 22. All patients then undergo bone marrow aspirate and biopsy on day 29.
Patients with response to remission induction therapy are randomized to 1 of 2 arms. Patients with no response are omitted from the study.
ARM I:
COURSE II (REMISSION CONSOLIDATION CHEMOTHERAPY): Patients receive cyclophosphamide IV on days 1 and 29, cytarabine IV or SC on days 1-4, 8-11, 29-32, and 36-39, mercaptopurine PO on days 1-14 and 29-42, and vincristine sulfate IV on days 15, 22, 43, and 50. Patients also receive pegylated L-aspiraginase IV on days 15 and 43, and methotrexate IT on days 1, 8, 15, and 22. Patients with CNS3 receive methotrexate IT only on days 1 and 8. CD20 positive (+) patients receive rituximab IV on days 1, 8, 29, and 36. Patients then undergo bone marrow aspirate and biopsy on day 56.
COURSE III (INTERIM MAINTENANCE CHEMOTHERAPY): Patients receive vincristine sulfate IV on days 1, 11, 21, 31, and 41, methotrexate IV and IT on days 1, 11, 21, 31, and 41, and pegylated L-aspiraginase IV on days 2 and 22. CD20+ patients receive rituximab IV on days 1 and 11.
COURSE IV (DELAYED INTENSIFICATION): Patients receive vincristine sulfate IV on days 1, 8, 15, 43, and 50, dexamethasone PO or IV BID on days 1-7 and 15-21, doxorubicin IV on days 1, 8, and 15, and pegylated L-aspiraginase IV on day 4, 5, or 6 and day 43. Patients also receive cyclophosphamide IV on day 29, cytarabine IV or SC on days 29-32 and 36-39, thioguanine PO on days 29-42 and methotrexate IT on days 1, 29, and 36. CD20+ patients receive rituximab IV on days 1 and 8. Patients then undergo bone marrow aspirate and biopsy on day 50.
COURSE V (MAINTENANCE THERAPY): Patients receive vincristine sulfate IV on days 1, 29, and 57, dexamethasone PO or IV BID on days 1-5, 29-33, and 57-61, and mercaptopurine PO on days 1-84. Patients also receive methotrexate IT or PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78. Treatment repeats every 12 weeks for up to 3 years in the absence of disease progression or unacceptable toxicity.
ARM II: Patients receive inotuzumab ozogamicin IV on days 1, 8, and 15 and undergo bone marrow aspirate and biopsy on day 28. Treatment repeats every 28 days for up to 2 courses in the absence of disease progression or unacceptable toxicity. Patients also receive remission consolidated chemotherapy, interim maintenance chemotherapy, delayed intensification, and maintenance therapy as in Arm I.
After completion of study treatment, patients are followed up every month for the first year, every 2 months for the second year, every 3 months for the third year, and every 6 months for the fourth through tenth year.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 310 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL |
Actual Study Start Date : | June 1, 2017 |
Estimated Primary Completion Date : | March 2023 |
Estimated Study Completion Date : | August 2024 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Arm I (frontline chemotherapy)
See detailed description.
|
Drug: Allopurinol
Given PO Drug: Cytarabine Given IT, IV, SC Drug: Daunorubicin Hydrochloride Given IV Drug: Vincristine Sulfate Given IV Drug: Dexamethasone Given PO or IV Drug: Pegylated L-Asparaginase Given IV Drug: Methotrexate Given IT, IV, PO Procedure: Bone Marrow Aspiration and Biopsy Undergo bone marrow aspiration and biopsy Drug: Cyclophosphamide Given IV Drug: Mercaptopurine Given PO Biological: Rituximab Given IV Drug: Thioguanine Given PO Other: Laboratory Biomarker Analysis Correlative studies |
Experimental: Arm II (frontline chemotherapy, inotuzumab ozogamicin)
Patients receive inotuzumab ozogamicin IV on days 1, 8, and 15 and undergo bone marrow aspirate and biopsy on day 28. Treatment repeats every 28 days for up to 2 courses in the absence of disease progression or unacceptable toxicity. Patients also receive remission consolidated chemotherapy, interim maintenance chemotherapy, delayed intensification, and maintenance therapy as in Arm I.
|
Drug: Allopurinol
Given PO Drug: Cytarabine Given IT, IV, SC Drug: Daunorubicin Hydrochloride Given IV Drug: Vincristine Sulfate Given IV Drug: Dexamethasone Given PO or IV Drug: Pegylated L-Asparaginase Given IV Drug: Methotrexate Given IT, IV, PO Procedure: Bone Marrow Aspiration and Biopsy Undergo bone marrow aspiration and biopsy Drug: Cyclophosphamide Given IV Drug: Mercaptopurine Given PO Biological: Rituximab Given IV Drug: Doxorubicin Given IV Drug: Thioguanine Given PO Biological: Inotuzumab Ozogamicin Given IV Other: Laboratory Biomarker Analysis Correlative studies |
- EFS [ Time Frame: Time from induction response to the time of progressive-disease, secondary malignancy, or death, assessed up to 3 years ]Will be compared using log-rank tests. EFS curves will be constructed using the Kaplan-Meier product limit method, and additional analyses will be done using the Cox proportional hazards model. The corresponding hazard ratio, 2- and 3-year EFS estimates will be assessed, and EFS medians along with their 95% confidence intervals for the two treatment arms.
- DFS [ Time Frame: Time from achievement of CR to the time of relapse and/or death, assessed up to 10 years ]
- OS [ Time Frame: Time from randomization to the time of death due to any cause, assessed up to 10 years ]Will be evaluated using Kaplan-Meier as well as Cox regression models.
- Proportion of patients who achieve CR or any response to induction therapy [ Time Frame: Up to 10 years ]Will be summarized as the proportion of patients who achieve any type of response to induction therapy divided by the number of all evaluable patients registered to this trial and who received at least one dose of induction therapy. Corresponding 95% binomial confidence intervals will also be calculated.
- Overall induction response rates [ Time Frame: Up to 10 years ]Will be summarized as the proportion of patients who achieve any type of response to induction therapy divided by the number of all evaluable patients registered to this trial and who received at least one dose of induction therapy. Corresponding 95% binomial confidence intervals will also be calculated.
- Incidence of adverse events as assessed by Common Terminology Criteria for Adverse Events version 4.0 [ Time Frame: Up to 10 years ]The maximum grade for each type of toxicity will be recorded for each patient, and frequency tables will be reviewed to determine toxicity patterns. In addition, all adverse event data that is graded as 3, 4, or 5 will be reviewed and classified as either "unrelated" or "unlikely to be related" to study treatment in the event of an actual relationship developing. The incidence of severe (grade 3+) adverse events or toxicities will be described for each treatment arm, but will also be compared between the arms. Fisher's exact tests will be used to quantitatively compare the incidence of severe as well as specific toxicities of interest between the treatment arms and we will graphically assess differences in maximum grades observed for toxicities between the arms. Tolerability of the treatment arms will be assessed through assessing the number of patients who required dose modifications and/or dose delays.
- Proportion of patients who go off treatment due to adverse reactions [ Time Frame: Up to 10 years ]Will be assessed within each of the treatment arms and differences explores in these measures between the arms.
- Proportion of patients who refuse further treatment for lesser toxicities that inhibit their willingness to continue participation on the trial [ Time Frame: Up to 10 years ]Will be assessed within each of the treatment arms and differences explores in these measures between the arms.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 39 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
REGISTRATION ELIGIBILITY CRITERIA (STEP 1)
- Newly diagnosed patients with CD-22 positive B-cell acute lymphoblastic leukemia (WHO criteria) are eligible. Patients with Burkitt type ALL are NOT eligible
- Patients who have BCR-ABL fusion transcript determined by fluorescence in situ hybridization (FISH) or real time-polymerase chain reaction (RT-PCR) or t(9;22)(q34;q11) by cytogenetics are not eligible and should be considered for enrollment on studies that incorporate imatinib during induction; please note: flow cytometry is to be performed at the local reference lab and must include assessment of CD20 and CD22 positivity, as well as CD29 and CD22 anti-positivity
- No prior therapy except for limited treatment (< 7 days) with corticosteroids or hydroxyurea and a single dose of intrathecal cytarabine
- No prior therapy for acute leukemia except emergency therapy (corticosteroids or hydroxyurea) for blast cell crisis, superior vena cava syndrome, or renal failure due to leukemic infiltration of the kidneys; when indicated, leukapheresis or exchange transfusion is recommended to reduce the WBC
- Single-dose intrathecal cytarabine is allowed prior to registration or prior to initiation of systematic therapy for patient convenience; systemic chemotherapy must begin within 72 hours of this intrathecal therapy
- Patients receiving prior steroid therapy are eligible for study; the dose and duration of previous steroid therapy should be carefully documented on case report forms
- Not pregnant and not nursing; for women of childbearing potential only, a negative urine or serum pregnancy test done =< 7 days prior to registration is required
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Patients with down syndrome are excluded from this study
- Aspartate aminotransferase (AST), alanine aminotransferase (ALT) =< 3 x upper limit of normal (ULN), unless suspected leukemic involvement of the liver
- Direct bilirubin =< 3 x upper limit of normal (ULN), unless suspected leukemic involvement of the liver
- Calculated (calc.) creatinine clearance >= 50 mL/min by Cockcroft-Gault
RANDOMIZATION ELIGIBILITY CRITERIA (STEP 2)
- Completion of remission induction therapy
-
Patients with M2 marrow or better are eligible; patients with M3 or M4 marrow (greater than 25% lymphoblasts) will not be eligible to be randomized
- Rating: M0, M1; Blast Cells (%): 0-5.0
- Rating: M2; Blast Cells (%): 5.1-25.0
- Rating: M3; Blast Cells (%): > 25-50
- Rating: M4; Blast Cells (%): > 50.0
- The term "blast cell" includes any cell that cannot be classified as a more mature normal element, and includes "leukemic cells," pathologic lymphocytes, and stem cells
- No ascites, effusions or significant edema
- Absolute neutrophil count (ANC) >= 1,000/mm^3
- Platelet count >= 100,000/mm^3
- Total bilirubin =< 1.5 x upper limit of normal (ULN), except for patients with known Gilbert's syndrome
- Aspartate aminotransferase (AST) =< 8 x upper limit of normal (ULN)
- Completion of first 12 weeks (12+ weeks) of maintenance therapy (Course V)
- Patient has at least 24 weeks (24+ weeks) remaining before end of maintenance therapy (Course V)
- Patient is in complete continuous first remission at entry into A041501-HO1
- Patient is receiving oral anti-metabolite chemotherapy during the maintenance phase of therapy; treatment plan must call for the following doses of antimetabolites: 6MP 75 mg/m2/day orally; methotrexate (MTX) 20 mg/m2/week orally (modification of 6 MP or MTX dosing based on laboratory or clinical parameters is acceptable)
- Patient is able and willing to use the Medication Event Monitoring System (MEMS) TrackCap (e.g. not using a pillbox)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03150693
Contact: Daniel J. DeAngelo, MD, PhD | 617-632-2645 | daniel_deangelo@dfci.harvard.edu |


United States, Alabama | |
University of Alabama at Birmingham Cancer Center | Recruiting |
Birmingham, Alabama, United States, 35233 | |
Contact: Site Public Contact 205-934-0220 tmyrick@uab.edu | |
Principal Investigator: Sravanti Rangaraju | |
United States, Alaska | |
Anchorage Associates in Radiation Medicine | Recruiting |
Anchorage, Alaska, United States, 98508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Radiation Therapy Center | Recruiting |
Anchorage, Alaska, United States, 99504 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Breast Care and Surgery LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Oncology and Hematology LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Women's Cancer Care | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Oncology Centre | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Alaska Medical Center | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Fairbanks Memorial Hospital | Recruiting |
Fairbanks, Alaska, United States, 99701 | |
Contact: Site Public Contact 907-458-3043 Veronica.Stevenson@foundationhealth.org | |
Principal Investigator: Nicholas DiBella | |
United States, Arizona | |
Kingman Regional Medical Center | Recruiting |
Kingman, Arizona, United States, 86401 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Mayo Clinic Hospital in Arizona | Suspended |
Phoenix, Arizona, United States, 85054 | |
Mayo Clinic in Arizona | Suspended |
Scottsdale, Arizona, United States, 85259 | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Recruiting |
Fort Smith, Arkansas, United States, 72903 | |
Contact: Site Public Contact 800-378-9373 | |
Principal Investigator: Jay W. Carlson | |
United States, California | |
Kaiser Permanente-Deer Valley Medical Center | Recruiting |
Antioch, California, United States, 94531 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
PCR Oncology | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
Burbank, California, United States, 91505 | |
Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Cancer Institute | Recruiting |
Clovis, California, United States, 93611 | |
Contact: Site Public Contact 559-387-1827 | |
Principal Investigator: Mohammed S. Bukari | |
University Oncology Associates | Recruiting |
Clovis, California, United States, 93611 | |
Contact: Site Public Contact 559-256-9680 | |
Principal Investigator: Mohammed S. Bukari | |
UC Irvine Health Cancer Center-Newport | Recruiting |
Costa Mesa, California, United States, 92627 | |
Contact: Site Public Contact 877-827-8839 | |
Principal Investigator: Deepa Jeyakumar | |
Kaiser Permanente Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Fresno Cancer Center | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Fresno | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Modesto | Recruiting |
Modesto, California, United States, 95356 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Oakland-Broadway | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Oakland | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 877-827-8839 ucstudy@uci.edu | |
Principal Investigator: Deepa Jeyakumar | |
Stanford Cancer Institute Palo Alto | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: Michaela Liedtke | |
Kaiser Permanente-Rancho Cordova Cancer Center | Recruiting |
Rancho Cordova, California, United States, 95670 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente- Marshall Medical Offices | Recruiting |
Redwood City, California, United States, 94063 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Redwood City | Recruiting |
Redwood City, California, United States, 94063 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Richmond | Recruiting |
Richmond, California, United States, 94801 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Rohnert Park Cancer Center | Recruiting |
Rohnert Park, California, United States, 94928 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
The Permanente Medical Group-Roseville Radiation Oncology | Recruiting |
Roseville, California, United States, 95678 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Downtown Commons | Recruiting |
Sacramento, California, United States, 95814 | |
Contact: Site Public Contact 877-642-4691 kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
University of California Davis Comprehensive Cancer Center | Recruiting |
Sacramento, California, United States, 95817 | |
Contact: Site Public Contact 916-734-3089 | |
Principal Investigator: Brian A. Jonas | |
Kaiser Permanente-South Sacramento | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
South Sacramento Cancer Center | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente - Sacramento | Recruiting |
Sacramento, California, United States, 95825 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-San Francisco | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Santa Teresa-San Jose | Recruiting |
San Jose, California, United States, 95119 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente San Leandro | Recruiting |
San Leandro, California, United States, 94577 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-San Rafael | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser San Rafael-Gallinas | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Medical Center - Santa Clara | Recruiting |
Santa Clara, California, United States, 95051 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Santa Rosa | Recruiting |
Santa Rosa, California, United States, 95403 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Cancer Treatment Center | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-South San Francisco | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Stockton | Recruiting |
Stockton, California, United States, 95210 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Medical Center-Vacaville | Recruiting |
Vacaville, California, United States, 95688 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Vallejo | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Walnut Creek | Recruiting |
Walnut Creek, California, United States, 94596 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
United States, Colorado | |
Rocky Mountain Cancer Centers-Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
The Medical Center of Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Boulder Community Hospital | Recruiting |
Boulder, Colorado, United States, 80301 | |
Contact: Site Public Contact 303-777-2663 jbloomfield@co-cancerresearch.org | |
Principal Investigator: Nicholas DiBella | |
Boulder Community Foothills Hospital | Recruiting |
Boulder, Colorado, United States, 80303 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Boulder | Recruiting |
Boulder, Colorado, United States, 80304 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers - Centennial | Recruiting |
Centennial, Colorado, United States, 80112 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Cancer Center of Colorado at Sloan's Lake | Suspended |
Denver, Colorado, United States, 80204 | |
National Jewish Health-Main Campus | Suspended |
Denver, Colorado, United States, 80206 | |
The Women's Imaging Center | Suspended |
Denver, Colorado, United States, 80209 | |
Colorado Blood Cancer Institute | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Presbyterian - Saint Lukes Medical Center - Health One | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Midtown | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
SCL Health Saint Joseph Hospital | Suspended |
Denver, Colorado, United States, 80218 | |
Rocky Mountain Cancer Centers-Rose | Recruiting |
Denver, Colorado, United States, 80220 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rose Medical Center | Recruiting |
Denver, Colorado, United States, 80220 | |
Contact: Site Public Contact 303-777-2663 ccrp@co-cancerresearch.org | |
Principal Investigator: Nicholas DiBella | |
Western Surgical Care | Recruiting |
Denver, Colorado, United States, 80220 | |
Contact: Site Public Contact 303-777-2663 | |
Principal Investigator: Nicholas DiBella | |
Mountain Blue Cancer Care Center - Swedish | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers - Swedish | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Swedish Medical Center | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
The Melanoma and Skin Cancer Institute | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact ryan.weight@theskincancerinstitute.com | |
Principal Investigator: Nicholas DiBella | |
National Jewish Health-Western Hematology Oncology | Suspended |
Golden, Colorado, United States, 80401 | |
Saint Mary's Hospital and Regional Medical Center | Suspended |
Grand Junction, Colorado, United States, 81501 | |
North Colorado Medical Center | Suspended |
Greeley, Colorado, United States, 80631 | |
Good Samaritan Medical Center | Suspended |
Lafayette, Colorado, United States, 80026 | |
Rocky Mountain Cancer Centers-Lakewood | Recruiting |
Lakewood, Colorado, United States, 80228 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Littleton | Recruiting |
Littleton, Colorado, United States, 80120 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Sky Ridge | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Sky Ridge Medical Center | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
McKee Medical Center | Suspended |
Loveland, Colorado, United States, 80539 | |
National Jewish Health-Northern Hematology Oncology | Suspended |
Thornton, Colorado, United States, 80260 | |
Rocky Mountain Cancer Centers-Thornton | Recruiting |
Thornton, Colorado, United States, 80260 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
SCL Health Lutheran Medical Center | Suspended |
Wheat Ridge, Colorado, United States, 80033 | |
United States, Connecticut | |
Smilow Cancer Hospital Care Center at Saint Francis | Recruiting |
Hartford, Connecticut, United States, 06105 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Nikolai A. Podoltsev | |
Smilow Cancer Center/Yale-New Haven Hospital | Recruiting |
New Haven, Connecticut, United States, 06510 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Nikolai A. Podoltsev | |
Yale University | Recruiting |
New Haven, Connecticut, United States, 06520 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Nikolai A. Podoltsev | |
United States, Florida | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7748 | |
Principal Investigator: Tareq Al Baghdadi | |
Memorial Regional Hospital/Joe DiMaggio Children's Hospital | Recruiting |
Hollywood, Florida, United States, 33021 | |
Contact: Site Public Contact 954-265-1847 OHR@mhs.net | |
Principal Investigator: Fernando M. Vargas Madueno | |
Miami Cancer Institute | Recruiting |
Miami, Florida, United States, 33176 | |
Contact: Site Public Contact 786-596-2000 | |
Principal Investigator: Talia Zahra | |
Orlando Health Cancer Institute | Recruiting |
Orlando, Florida, United States, 32806 | |
Contact: Site Public Contact 321-841-7246 CancerClinicalTrials@orlandohealth.com | |
Principal Investigator: Jose E. Sarriera | |
Memorial Hospital West | Recruiting |
Pembroke Pines, Florida, United States, 33028 | |
Contact: Site Public Contact 954-265-4325 | |
Principal Investigator: Fernando M. Vargas Madueno | |
United States, Georgia | |
Emory University Hospital/Winship Cancer Institute | Recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Site Public Contact 404-778-1868 | |
Principal Investigator: William G. Blum | |
Augusta University Medical Center | Recruiting |
Augusta, Georgia, United States, 30912 | |
Contact: Site Public Contact 706-721-2388 ga_cares@augusta.edu | |
Principal Investigator: Vamsi Kota | |
United States, Hawaii | |
Hawaii Cancer Care - Savio | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-539-2273 info@hawaiicancercare.com | |
Principal Investigator: Craig S. Boddy | |
Pali Momi Medical Center | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-486-6000 | |
Principal Investigator: Craig S. Boddy | |
Queen's Cancer Center - Pearlridge | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-487-7447 | |
Principal Investigator: Craig S. Boddy | |
The Cancer Center of Hawaii-Pali Momi | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-678-9000 | |
Principal Investigator: Craig S. Boddy | |
Island Urology-Hilo | Suspended |
Hilo, Hawaii, United States, 96720 | |
Hawaii Cancer Care Inc - Waterfront Plaza | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-524-6115 i.webster@hawaiicancercare.com | |
Principal Investigator: Craig S. Boddy | |
Island Urology | Suspended |
Honolulu, Hawaii, United States, 96813 | |
Queen's Cancer Cenrer - POB I | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-532-0315 | |
Principal Investigator: Craig S. Boddy | |
Queen's Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-545-8548 | |
Principal Investigator: Craig S. Boddy | |
Straub Clinic and Hospital | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-522-4333 | |
Principal Investigator: Craig S. Boddy | |
University of Hawaii Cancer Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-586-2979 | |
Principal Investigator: Craig S. Boddy | |
Hawaii Cancer Care Inc-Liliha | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-536-4888 | |
Principal Investigator: Craig S. Boddy | |
Kuakini Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-547-9816 | |
Principal Investigator: Craig S. Boddy | |
Queen's Cancer Center - Kuakini | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-531-8521 | |
Principal Investigator: Craig S. Boddy | |
The Cancer Center of Hawaii-Liliha | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-547-6881 | |
Principal Investigator: Craig S. Boddy | |
Kaiser Permanente Moanalua Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96819 | |
Contact: Site Public Contact 808-432-5195 shelley.a.clark@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kapiolani Medical Center for Women and Children | Recruiting |
Honolulu, Hawaii, United States, 96826 | |
Contact: Site Public Contact 808-983-6090 | |
Principal Investigator: Craig S. Boddy | |
Wilcox Memorial Hospital and Kauai Medical Clinic | Recruiting |
Lihue, Hawaii, United States, 96766 | |
Contact: Site Public Contact 808-535-7960 | |
Principal Investigator: Craig S. Boddy | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
Caldwell, Idaho, United States, 83605 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Health - Coeur d'Alene | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Walter Knox Memorial Hospital | Recruiting |
Emmett, Idaho, United States, 83617 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Idaho Urologic Institute-Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Clinic Cancer Services - Post Falls | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Saint Anthony's Health | Recruiting |
Alton, Illinois, United States, 62002 | |
Contact: Site Public Contact 618-463-5623 | |
Principal Investigator: Jay W. Carlson | |
Loyola Center for Health at Burr Ridge | Recruiting |
Burr Ridge, Illinois, United States, 60527 | |
Contact: Site Public Contact 708-216-9000 | |
Principal Investigator: Scott E. Smith | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Shira N. Dinner | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Melissa L. Larson | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: John G. Quigley | |
University of Chicago Comprehensive Cancer Center | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Wendy Stock | |
NorthShore University HealthSystem-Evanston Hospital | Recruiting |
Evanston, Illinois, United States, 60201 | |
Contact: Site Public Contact 847-570-2109 | |
Principal Investigator: Lynne S. Kaminer | |
NorthShore University HealthSystem-Glenbrook Hospital | Recruiting |
Glenview, Illinois, United States, 60026 | |
Contact: Site Public Contact 847-570-2109 | |
Principal Investigator: Lynne S. Kaminer | |
NorthShore University HealthSystem-Highland Park Hospital | Recruiting |
Highland Park, Illinois, United States, 60035 | |
Contact: Site Public Contact 847-570-2109 | |
Principal Investigator: Lynne S. Kaminer | |
Loyola Medicine Homer Glen | Recruiting |
Homer Glen, Illinois, United States, 60491 | |
Contact: Site Public Contact 708-216-9000 | |
Principal Investigator: Scott E. Smith | |
Northwestern Medicine Lake Forest Hospital | Active, not recruiting |
Lake Forest, Illinois, United States, 60045 | |
Rush Cancer Care in Lisle | Recruiting |
Lisle, Illinois, United States, 60532 | |
Contact: Site Public Contact 312-226-2371 | |
Principal Investigator: Melissa L. Larson | |
Loyola University Medical Center | Recruiting |
Maywood, Illinois, United States, 60153 | |
Contact: Site Public Contact 708-226-4357 | |
Principal Investigator: Scott E. Smith | |
Marjorie Weinberg Cancer Center at Loyola-Gottlieb | Recruiting |
Melrose Park, Illinois, United States, 60160 | |
Contact: Site Public Contact 708-450-4554 | |
Principal Investigator: Scott E. Smith | |
Good Samaritan Regional Health Center | Recruiting |
Mount Vernon, Illinois, United States, 62864 | |
Contact: Site Public Contact 618-242-4600 | |
Principal Investigator: Jay W. Carlson | |
UC Comprehensive Cancer Center at Silver Cross | Recruiting |
New Lenox, Illinois, United States, 60451 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Wendy Stock | |
University of Chicago Medicine-Orland Park | Recruiting |
Orland Park, Illinois, United States, 60462 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Wendy Stock | |
United States, Iowa | |
Saint Anthony Regional Hospital | Active, not recruiting |
Carroll, Iowa, United States, 51401 | |
Blank Children's Hospital | Active, not recruiting |
Des Moines, Iowa, United States, 50309 | |
Iowa Methodist Medical Center | Active, not recruiting |
Des Moines, Iowa, United States, 50309 | |
Medical Oncology and Hematology Associates-Des Moines | Active, not recruiting |
Des Moines, Iowa, United States, 50309 | |
Broadlawns Medical Center | Active, not recruiting |
Des Moines, Iowa, United States, 50314 | |
Iowa Lutheran Hospital | Active, not recruiting |
Des Moines, Iowa, United States, 50316 | |
Trinity Regional Medical Center | Active, not recruiting |
Fort Dodge, Iowa, United States, 50501 | |
University of Iowa/Holden Comprehensive Cancer Center | Recruiting |
Iowa City, Iowa, United States, 52242 | |
Contact: Site Public Contact 800-237-1225 | |
Principal Investigator: Grerk Sutamtewagul | |
Methodist West Hospital | Active, not recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
United States, Kansas | |
Central Care Cancer Center - Garden City | Recruiting |
Garden City, Kansas, United States, 67846 | |
Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
Principal Investigator: Jay W. Carlson | |
Central Care Cancer Center - Great Bend | Recruiting |
Great Bend, Kansas, United States, 67530 | |
Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
Principal Investigator: Jay W. Carlson | |
University of Kansas Cancer Center | Recruiting |
Kansas City, Kansas, United States, 66160 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Kenneth Byrd | |
Lawrence Memorial Hospital | Suspended |
Lawrence, Kansas, United States, 66044 | |
University of Kansas Hospital-Westwood Cancer Center | Recruiting |
Westwood, Kansas, United States, 66205 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Kenneth Byrd | |
Cancer Center of Kansas-Wichita Medical Arts Tower | Recruiting |
Wichita, Kansas, United States, 67208 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Ascension Via Christi Hospitals Wichita | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 800-362-0070 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Wichita | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Wesley Medical Center | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
United States, Kentucky | |
University of Kentucky/Markey Cancer Center | Recruiting |
Lexington, Kentucky, United States, 40536 | |
Contact: Site Public Contact 859-257-3379 | |
Principal Investigator: Reshma Ramlal | |
United States, Louisiana | |
Ochsner Health Center-Summa | Active, not recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Medical Center of Baton Rouge | Active, not recruiting |
Baton Rouge, Louisiana, United States, 70816 | |
Ochsner High Grove | Active, not recruiting |
Baton Rouge, Louisiana, United States, 70836 | |
Ochsner Medical Center Jefferson | Active, not recruiting |
New Orleans, Louisiana, United States, 70121 | |
United States, Maryland | |
University of Maryland/Greenebaum Cancer Center | Recruiting |
Baltimore, Maryland, United States, 21201 | |
Contact: Site Public Contact 800-888-8823 | |
Principal Investigator: Ashkan Emadi | |
United States, Massachusetts | |
Massachusetts General Hospital Cancer Center | Recruiting |
Boston, Massachusetts, United States, 02114 | |
Contact: Site Public Contact 877-726-5130 | |
Principal Investigator: Daniel J. DeAngelo | |
Beth Israel Deaconess Medical Center | Suspended |
Boston, Massachusetts, United States, 02215 | |
Dana-Farber Cancer Institute | Recruiting |
Boston, Massachusetts, United States, 02215 | |
Contact: Site Public Contact 877-442-3324 | |
Principal Investigator: Daniel J. DeAngelo | |
United States, Michigan | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Bronson Battle Creek | Recruiting |
Battle Creek, Michigan, United States, 49017 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Caro Cancer Center | Recruiting |
Caro, Michigan, United States, 48723 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hematology Oncology Consultants-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Newland Medical Associates-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Wayne State University/Karmanos Cancer Institute | Recruiting |
Detroit, Michigan, United States, 48201 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Jay Yang | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Weisberg Cancer Treatment Center | Recruiting |
Farmington Hills, Michigan, United States, 48334 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Jay Yang | |
Genesee Cancer and Blood Disease Treatment Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 810-762-8038 wstrong@ghci.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesee Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 810-762-8038 wstrong@ghci.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 810-762-8038 wstrong@ghci.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hurley Medical Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 810-762-8038 wstrong@ghci.org | |
Principal Investigator: Tareq Al Baghdadi | |
Helen DeVos Children's Hospital at Spectrum Health | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Mercy Health Saint Mary's | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Bronson Methodist Hospital | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Borgess Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49009 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Borgess Medical Center | Recruiting |
Kalamazoo, Michigan, United States, 49048 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 517-364-9400 | |
Principal Investigator: Tareq Al Baghdadi | |
Hope Cancer Clinic | Suspended |
Livonia, Michigan, United States, 48154 | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
Marlette, Michigan, United States, 48453 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Mercy Health Mercy Campus | Recruiting |
Muskegon, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Lakeland Hospital Niles | Recruiting |
Niles, Michigan, United States, 49120 | |
Contact: Site Public Contact 616-391-1230 | |
Principal Investigator: Kathleen J. Yost | |
Cancer and Hematology Centers of Western Michigan - Norton Shores | Recruiting |
Norton Shores, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 connie.szczepanek@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
21st Century Oncology-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hope Cancer Center | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Newland Medical Associates-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Spectrum Health Reed City Hospital | Recruiting |
Reed City, Michigan, United States, 49677 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
Rochester Hills, Michigan, United States, 48309 | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
Saginaw, Michigan, United States, 48604 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lakeland Medical Center Saint Joseph | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Marie Yeager Cancer Center | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Ascension Saint Joseph Hospital | Recruiting |
Tawas City, Michigan, United States, 48764 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Munson Medical Center | Recruiting |
Traverse City, Michigan, United States, 49684 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Advanced Breast Care Center PLLC | Recruiting |
Warren, Michigan, United States, 48088 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Macomb Hematology Oncology PC | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
West Branch, Michigan, United States, 48661 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Tareq Al Baghdadi | |
Metro Health Hospital | Recruiting |
Wyoming, Michigan, United States, 49519 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Huron Gastroenterology PC | Recruiting |
Ypsilanti, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
United States, Minnesota | |
Riverwood Healthcare Center | Recruiting |
Aitkin, Minnesota, United States, 56431 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Joseph's Medical Center | Recruiting |
Brainerd, Minnesota, United States, 56401 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology - Burnsville | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Cambridge Medical Center | Recruiting |
Cambridge, Minnesota, United States, 55008 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health - Deer River Clinic | Recruiting |
Deer River, Minnesota, United States, 56636 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's - Detroit Lakes Clinic | Recruiting |
Detroit Lakes, Minnesota, United States, 56501 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Cancer Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's Medical Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Miller-Dwan Hospital | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Lake Region Healthcare Corporation-Cancer Care | Recruiting |
Fergus Falls, Minnesota, United States, 56537 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health - Fosston | Recruiting |
Fosston, Minnesota, United States, 56542 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health Hibbing Clinic | Recruiting |
Hibbing, Minnesota, United States, 55746 | |
Contact: Site Public Contact 218-786-3308 | |
Principal Investigator: Bret E. Friday | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Monticello Cancer Center | Recruiting |
Monticello, Minnesota, United States, 55362 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
New Ulm Medical Center | Recruiting |
New Ulm, Minnesota, United States, 56073 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health - Park Rapids | Recruiting |
Park Rapids, Minnesota, United States, 56470 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Northland Medical Center | Recruiting |
Princeton, Minnesota, United States, 55371 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Mayo Clinic in Rochester | Recruiting |
Rochester, Minnesota, United States, 55905 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Mark R. Litzow | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health Sandstone | Recruiting |
Sandstone, Minnesota, United States, 55072 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health Virginia Clinic | Recruiting |
Virginia, Minnesota, United States, 55792 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Fairview Lakes Medical Center | Recruiting |
Wyoming, Minnesota, United States, 55092 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
Ballwin, Missouri, United States, 63011 | |
Contact: Site Public Contact 314-251-7058 | |
Principal Investigator: Jay W. Carlson | |
Central Care Cancer Center - Bolivar | Recruiting |
Bolivar, Missouri, United States, 65613 | |
Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
Principal Investigator: Jay W. Carlson | |
Cox Cancer Center Branson | Recruiting |
Branson, Missouri, United States, 65616 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center at West County Hospital | Recruiting |
Creve Coeur, Missouri, United States, 63141 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Geoffrey L. Uy | |
Freeman Health System | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Joplin | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-7504 research@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Heartland Regional Medical Center | Recruiting |
Saint Joseph, Missouri, United States, 64506 | |
Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Washington University School of Medicine | Recruiting |
Saint Louis, Missouri, United States, 63110 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Geoffrey L. Uy | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center-South County | Recruiting |
Saint Louis, Missouri, United States, 63129 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Geoffrey L. Uy | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center at Saint Peters Hospital | Recruiting |
Saint Peters, Missouri, United States, 63376 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Geoffrey L. Uy | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Washington | Recruiting |
Washington, Missouri, United States, 63090 | |
Contact: Site Public Contact 636-390-1600 | |
Principal Investigator: Jay W. Carlson | |
United States, Montana | |
Community Hospital of Anaconda | Recruiting |
Anaconda, Montana, United States, 59711 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Vincent Healthcare | Suspended |
Billings, Montana, United States, 59101 | |
Saint Vincent Frontier Cancer Center | Suspended |
Billings, Montana, United States, 59102 | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint James Community Hospital and Cancer Treatment Center | Suspended |
Butte, Montana, United States, 59701 | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Great Falls Clinic | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Patrick Hospital - Community Hospital | Recruiting |
Missoula, Montana, United States, 59802 | |
Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Medical Hospital | Recruiting |
Missoula, Montana, United States, 59804 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
Nebraska Medicine-Village Pointe | Suspended |
Omaha, Nebraska, United States, 68118 | |
University of Nebraska Medical Center | Suspended |
Omaha, Nebraska, United States, 68198 | |
United States, Nevada | |
Carson Tahoe Regional Medical Center | Recruiting |
Carson City, Nevada, United States, 89703 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Horizon Ridge | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Seven Hills | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Southeast Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pebble | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pecos | Recruiting |
Las Vegas, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Desert West Surgery | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Charleston | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Medical Center of Southern Nevada | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89103 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Centers of Nevada Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Las Vegas | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Sunrise Hospital and Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Prostate Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Sunset | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Southwest | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Centers of Nevada Southeast | Recruiting |
Las Vegas, Nevada, United States, 89119 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Ann M Wierman MD LTD | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Vegas Tenaya | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Cathedral Rock | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Smoke Ranch | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@smcrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at MountainView | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Recruiting |
Las Vegas, Nevada, United States, 89135 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Town Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Summerlin | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Summerlin Hospital Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89148-2405 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Central Valley | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada-Pahrump | Recruiting |
Pahrump, Nevada, United States, 89048 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Saint Mary's Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89503 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Associates | Recruiting |
Reno, Nevada, United States, 89509 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Mexico | |
University of New Mexico Cancer Center | Active, not recruiting |
Albuquerque, New Mexico, United States, 87102 | |
United States, New York | |
Roswell Park Cancer Institute | Recruiting |
Buffalo, New York, United States, 14263 | |
Contact: Site Public Contact 800-767-9355 askroswell@roswellpark.org | |
Principal Investigator: Eunice S. Wang | |
Northwell Health/Center for Advanced Medicine | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Bradley H. Goldberg | |
North Shore University Hospital | Recruiting |
Manhasset, New York, United States, 11030 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Bradley H. Goldberg | |
Long Island Jewish Medical Center | Recruiting |
New Hyde Park, New York, United States, 11040 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Bradley H. Goldberg | |
Mount Sinai Hospital | Recruiting |
New York, New York, United States, 10029 | |
Contact: Site Public Contact 212-824-7309 CCTO@mssm.edu | |
Principal Investigator: Michal Bar-Natan | |
NYP/Weill Cornell Medical Center | Suspended |
New York, New York, United States, 10065 | |
Upstate Cancer Center at Oneida | Active, not recruiting |
Oneida, New York, United States, 13421 | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
Stony Brook University Medical Center | Recruiting |
Stony Brook, New York, United States, 11794 | |
Contact: Site Public Contact 800-862-2215 | |
Principal Investigator: Laura E. Hogan | |
State University of New York Upstate Medical University | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Teresa C. Gentile | |
United States, North Carolina | |
UNC Lineberger Comprehensive Cancer Center | Recruiting |
Chapel Hill, North Carolina, United States, 27599 | |
Contact: Site Public Contact 877-668-0683 cancerclinicaltrials@med.unc.edu | |
Principal Investigator: Matthew C. Foster | |
Duke University Medical Center | Recruiting |
Durham, North Carolina, United States, 27710 | |
Contact: Site Public Contact 888-275-3853 | |
Principal Investigator: Jeffrey Crawford | |
East Carolina University | Recruiting |
Greenville, North Carolina, United States, 27834 | |
Contact: Site Public Contact 252-744-1015 eubankss@ecu.edu | |
Principal Investigator: Darla K. Liles | |
Wake Forest University Health Sciences | Recruiting |
Winston-Salem, North Carolina, United States, 27157 | |
Contact: Site Public Contact 336-713-6771 | |
Principal Investigator: Bayard L. Powell | |
United States, North Dakota | |
Essentia Health Cancer Center-South University Clinic | Recruiting |
Fargo, North Dakota, United States, 58103 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health - Jamestown Clinic | Recruiting |
Jamestown, North Dakota, United States, 58401 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
United States, Ohio | |
University of Cincinnati Cancer Center-UC Medical Center | Recruiting |
Cincinnati, Ohio, United States, 45219 | |
Contact: Site Public Contact 513-584-7698 cancer@uchealth.com | |
Principal Investigator: Emily K. Curran | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Brenda W. Cooper | |
Cleveland Clinic Foundation | Recruiting |
Cleveland, Ohio, United States, 44195 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Anjali S. Advani | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Meixiao Long | |
University of Cincinnati Cancer Center-West Chester | Recruiting |
West Chester, Ohio, United States, 45069 | |
Contact: Site Public Contact 513-584-7698 cancer@uchealth.com | |
Principal Investigator: Emily K. Curran | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Mohamad Khawandanah | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
United States, Oregon | |
Saint Alphonsus Medical Center-Baker City | Recruiting |
Baker City, Oregon, United States, 97814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Charles Health System | Recruiting |
Bend, Oregon, United States, 97701 | |
Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
Principal Investigator: Alison K. Conlin | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Bay Area Hospital | Recruiting |
Coos Bay, Oregon, United States, 97420 | |
Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
Principal Investigator: Alison K. Conlin | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Ontario | Recruiting |
Ontario, Oregon, United States, 97914 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Oregon Health and Science University | Recruiting |
Portland, Oregon, United States, 97239 | |
Contact: Site Public Contact 503-494-1080 trials@ohsu.edu | |
Principal Investigator: Brandon M. Hayes-Lattin | |
Saint Charles Health System-Redmond | Recruiting |
Redmond, Oregon, United States, 97756 | |
Contact: Site Public Contact 541-706-2909 | |
Principal Investigator: Alison K. Conlin | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 610-402-9543 Morgan_M.Horton@lvhn.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lehigh Valley Hospital - Muhlenberg | Recruiting |
Bethlehem, Pennsylvania, United States, 18017 | |
Contact: Site Public Contact 610-402-9543 Morgan_M.Horton@lvhn.org | |
Principal Investigator: Tareq Al Baghdadi | |
Pocono Medical Center | Recruiting |
East Stroudsburg, Pennsylvania, United States, 18301 | |
Contact: Site Public Contact 610-402-9543 Morgan_M.Horton@lvhn.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lehigh Valley Hospital-Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 610-402-9543 Morgan_M.Horton@lvhn.org | |
Principal Investigator: Tareq Al Baghdadi | |
University of Pennsylvania/Abramson Cancer Center | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Contact: Site Public Contact 800-474-9892 | |
Principal Investigator: Keith W. Pratz | |
Thomas Jefferson University Hospital | Recruiting |
Philadelphia, Pennsylvania, United States, 19107 | |
Contact: Site Public Contact 215-600-9151 ONCTrialNow@jefferson.edu | |
Principal Investigator: Lindsay Wilde | |
University of Pittsburgh Cancer Institute (UPCI) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Annie P. Im | |
United States, Rhode Island | |
Rhode Island Hospital | Recruiting |
Providence, Rhode Island, United States, 02903 | |
Contact: Site Public Contact 401-444-1488 | |
Principal Investigator: Pamela Egan | |
Miriam Hospital | Recruiting |
Providence, Rhode Island, United States, 02906 | |
Contact: Site Public Contact 401-793-2224 | |
Principal Investigator: Pamela Egan | |
United States, South Carolina | |
Prisma Health Cancer Institute - Spartanburg | Recruiting |
Boiling Springs, South Carolina, United States, 29316 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Laurens | Recruiting |
Clinton, South Carolina, United States, 29325 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Richland Hospital | Recruiting |
Columbia, South Carolina, United States, 29203 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Easley | Recruiting |
Easley, South Carolina, United States, 29640 | |
Contact: Site Public Contact 864-522-2066 Kim.Williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Saint Francis Hospital | Recruiting |
Greenville, South Carolina, United States, 29601 | |
Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
Principal Investigator: Howland E. Crosswell | |
BI-LO Charities Children's Cancer Center | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Butternut | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Faris | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Greenville Memorial Hospital | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Saint Francis Cancer Center | Recruiting |
Greenville, South Carolina, United States, 29607 | |
Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
Principal Investigator: Howland E. Crosswell | |
Prisma Health Cancer Institute - Eastside | Recruiting |
Greenville, South Carolina, United States, 29615 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Greer | Recruiting |
Greer, South Carolina, United States, 29650 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Seneca | Recruiting |
Seneca, South Carolina, United States, 29672 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
United States, Texas | |
Houston Methodist Hospital | Active, not recruiting |
Houston, Texas, United States, 77030 | |
Covenant Medical Center-Lakeside | Recruiting |
Lubbock, Texas, United States, 79410 | |
Contact: Site Public Contact 806-725-8000 jaccresearch@covhs.org | |
Principal Investigator: Kiran K. Yalamanchili | |
United States, Utah | |
American Fork Hospital / Huntsman Intermountain Cancer Center | Recruiting |
American Fork, Utah, United States, 84003 | |
Contact: Site Public Contact 801-855-4100 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Sandra L Maxwell Cancer Center | Recruiting |
Cedar City, Utah, United States, 84720 | |
Contact: Site Public Contact 435-868-5680 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Logan Regional Hospital | Recruiting |
Logan, Utah, United States, 84321 | |
Contact: Site Public Contact 435-716-6400 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Intermountain Medical Center | Recruiting |
Murray, Utah, United States, 84107 | |
Contact: Site Public Contact 801-507-3950 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
McKay-Dee Hospital Center | Recruiting |
Ogden, Utah, United States, 84403 | |
Contact: Site Public Contact 801-387-7426 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Utah Valley Regional Medical Center | Recruiting |
Provo, Utah, United States, 84604 | |
Contact: Site Public Contact 801-357-7965 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Riverton Hospital | Recruiting |
Riverton, Utah, United States, 84065 | |
Contact: Site Public Contact 801-507-3950 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Dixie Medical Center Regional Cancer Center | Recruiting |
Saint George, Utah, United States, 84770 | |
Contact: Site Public Contact 435-688-4167 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Utah Cancer Specialists-Salt Lake City | Recruiting |
Salt Lake City, Utah, United States, 84106 | |
Contact: Site Public Contact 801-933-6070 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
Huntsman Cancer Institute/University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84112 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Tibor J. Kovacsovics | |
LDS Hospital | Recruiting |
Salt Lake City, Utah, United States, 84143 | |
Contact: Site Public Contact 801-408-1347 officeofresearch@imail.org | |
Principal Investigator: Julie D. Asch | |
United States, Virginia | |
Inova Schar Cancer Institute | Recruiting |
Fairfax, Virginia, United States, 22031 | |
Contact: Site Public Contact 703-720-5210 Stephanie.VanBebber@inova.org | |
Principal Investigator: Danielle A. Shafer | |
Inova Fairfax Hospital | Recruiting |
Falls Church, Virginia, United States, 22042 | |
Contact: Site Public Contact 703-208-6650 Stephanie.VanBebber@inova.org | |
Principal Investigator: Danielle A. Shafer | |
Virginia Commonwealth University/Massey Cancer Center | Recruiting |
Richmond, Virginia, United States, 23298 | |
Contact: Site Public Contact CTOclinops@vcu.edu | |
Principal Investigator: Keri R. Maher | |
United States, Washington | |
Providence Regional Cancer System-Aberdeen | Recruiting |
Aberdeen, Washington, United States, 98520 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Overlake Medical Center | Recruiting |
Bellevue, Washington, United States, 98004 | |
Contact: Site Public Contact 425-688-5407 OHMCResearch@overlakehospital.org | |
Principal Investigator: John A. Ellerton | |
PeaceHealth Saint Joseph Medical Center | Recruiting |
Bellingham, Washington, United States, 98225 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Centralia | Recruiting |
Centralia, Washington, United States, 98531 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Kadlec Clinic Hematology and Oncology | Recruiting |
Kennewick, Washington, United States, 99336 | |
Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Lacey | Recruiting |
Lacey, Washington, United States, 98503 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth Saint John Medical Center | Recruiting |
Longview, Washington, United States, 98632 | |
Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Jefferson Healthcare | Recruiting |
Port Townsend, Washington, United States, 98368 | |
Contact: Site Public Contact 360-344-3091 | |
Principal Investigator: Nicholas DiBella | |
Valley Medical Center | Recruiting |
Renton, Washington, United States, 98055 | |
Contact: Site Public Contact 425-228-3440 research@valleymed.org | |
Principal Investigator: John A. Ellerton | |
Pacific Gynecology Specialists | Suspended |
Seattle, Washington, United States, 98104 | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Kaiser Permanente Washington | Active, not recruiting |
Seattle, Washington, United States, 98112 | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Cherry Hill | Recruiting |
Seattle, Washington, United States, 98122-5711 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth United General Medical Center | Recruiting |
Sedro-Woolley, Washington, United States, 98284 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Shelton | Recruiting |
Shelton, Washington, United States, 98584 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth Southwest Medical Center | Recruiting |
Vancouver, Washington, United States, 98664 | |
Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Mary Regional Cancer Center | Recruiting |
Walla Walla, Washington, United States, 99362 | |
Contact: Site Public Contact 509-897-5993 Cheryl.Dodd@providence.org | |
Principal Investigator: Alison K. Conlin | |
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital | Recruiting |
Yakima, Washington, United States, 98902 | |
Contact: Site Public Contact 509-574-3535 Memorial-ClinicalTrials@yvmh.org | |
Principal Investigator: John A. Ellerton | |
Providence Regional Cancer System-Yelm | Recruiting |
Yelm, Washington, United States, 98597 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Wisconsin | |
Duluth Clinic Ashland | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Northwest Wisconsin Cancer Center | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health-Hayward Clinic | Recruiting |
Hayward, Wisconsin, United States, 54843 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
University of Wisconsin Hospital and Clinics | Recruiting |
Madison, Wisconsin, United States, 53792 | |
Contact: Site Public Contact 800-622-8922 | |
Principal Investigator: Ryan J. Mattison | |
Marshfield Medical Center-Marshfield | Recruiting |
Marshfield, Wisconsin, United States, 54449 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Chady A. Leon | |
Medical College of Wisconsin | Recruiting |
Milwaukee, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-805-3666 | |
Principal Investigator: Guru Subramanian Guru Murthy | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health-Spooner Clinic | Recruiting |
Spooner, Wisconsin, United States, 54801 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's Hospital - Superior | Recruiting |
Superior, Wisconsin, United States, 54880 | |
Contact: Site Public Contact 701-364-6272 | |
Principal Investigator: Bret E. Friday | |
United States, Wyoming | |
Cheyenne Regional Medical Center-West | Recruiting |
Cheyenne, Wyoming, United States, 82001 | |
Contact: Site Public Contact 303-777-2663 ccrp@co-cancerresearch.org | |
Principal Investigator: Nicholas DiBella | |
Billings Clinic-Cody | Recruiting |
Cody, Wyoming, United States, 82414 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Welch Cancer Center | Recruiting |
Sheridan, Wyoming, United States, 82801 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Canada, Alberta | |
Tom Baker Cancer Centre | Recruiting |
Calgary, Alberta, Canada, T2N 4N2 | |
Contact: Site Public Contact 403-521-3433 | |
Principal Investigator: Mary L. Savoie | |
Canada, Manitoba | |
CancerCare Manitoba | Recruiting |
Winnipeg, Manitoba, Canada, R3E 0V9 | |
Contact: Site Public Contact 866-561-1026 ctu_web@cancercare.mb.ca | |
Principal Investigator: David Szwajcer | |
Canada, Nova Scotia | |
QEII Health Sciences Centre/Nova Scotia Health Authority | Recruiting |
Halifax, Nova Scotia, Canada, B3H 2Y9 | |
Contact: Site Public Contact 902-473-6000 | |
Principal Investigator: Nicholas A. Forward | |
Canada, Ontario | |
Ottawa Hospital and Cancer Center-General Campus | Recruiting |
Ottawa, Ontario, Canada, K1H 8L6 | |
Contact: Site Public Contact 613-761-4395 | |
Principal Investigator: Jill Fulcher | |
Canada, Quebec | |
Jewish General Hospital | Recruiting |
Montreal, Quebec, Canada, H3T 1E2 | |
Contact: Site Public Contact 514-340-8222 ext 8248 | |
Principal Investigator: Sarit E. Assouline |
Study Chair: | daniel_deangelo@dfci.harvard.edu J. DeAngelo, MD, PhD | Dana-Farber Cancer Institute |
Responsible Party: | Alliance for Clinical Trials in Oncology |
ClinicalTrials.gov Identifier: | NCT03150693 |
Other Study ID Numbers: |
A041501 NCI-2016-01981 ( Registry Identifier: Clinical Trial Reporting Program ) U10CA180821 ( U.S. NIH Grant/Contract ) |
First Posted: | May 12, 2017 Key Record Dates |
Last Update Posted: | April 19, 2022 |
Last Verified: | April 2022 |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Lymphoid Neoplasms by Histologic Type Neoplasms Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Cytarabine Dexamethasone Cyclophosphamide Rituximab Doxorubicin Methotrexate |
Vincristine Daunorubicin Asparaginase Mercaptopurine Thioguanine Inotuzumab Ozogamicin Pegaspargase Allopurinol Immunosuppressive Agents Immunologic Factors Physiological Effects of Drugs Antirheumatic Agents Antineoplastic Agents, Alkylating Alkylating Agents Molecular Mechanisms of Pharmacological Action |